Please login to the form below

Not currently logged in
Email:
Password:

Helen Parfitt joins Research Partnership

She takes on role as head of its Therapy Watch market tracking tool

Helen ParfittResearch Partnership has appointed Helen Parfitt as its new director, head of Therapy Watch - a ‘real-time’ syndicated global market tracking tool - in a role that will see her based at the firm’s head office in London.

Prior to joining the company, Parfitt has previously worked for IMS Health (now QuintilesIMS) as its director of core data assets, global technology services and operations, and subsequently as commercial director for M3 Group’s European division.

Her new role will see her join research directors Julia Godfrey and Laurent Chanroux in supporting the continued expansion of Therapy Watch, which currently runs global monitors in auto-immune, virology, oncology and nephrology.

She will also focus on the firm’s recently expanded oncology portfolio, which has added squamous cell carcinoma of the head and neck (SCCHN) and chronic myeloid leukaemia (CML) to its coverage.

Mark Jeffery, founding director of Research Partnership, said: “Helen brings with her a wealth of knowledge and expertise, her experience at GSK and Schering-Plough means she has also developed a strong understanding of clients’ needs.

“I believe she will be a strong asset to the Therapy Watch team and we look forward to her contributing to its continued growth and development.”

8th May 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Harness the power of data to map new patient pathways
Oli Hudson, of Wilmington Healthcare, explains why pharma needs to put data at the heart of its bid to support the NHS Reset...
What NORD’s RareInsights® 30-year comparative analysis means to us and our clients at OPEN Health
...
Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...

Infographics